Toxoplasma gondii is a specialized intracellular parasite of the terminal complex phylum that invades nucleated cells and can infect almost all warm-blooded vertebrates. Although most human infections with Toxoplasma gondii are recessive, it can cause abortion in pregnant women, fetal death, and fatal encephalitis in AIDS patients. As an important pathogen for clinical and veterinary research, Toxoplasma gondii is easy to culture in vitro and genetically manipulated, making it an excellent model for studying intracellular parasites. Molecular genetic tools for studying Toxoplasma gondii were rapidly developed at the end of the 20th century, and short and stable in vitro transformation of Toxoplasma gondii has become a routine tool. Endogenous or heterologous proteins can be expressed in this way in different parts of Toxoplasma gondii.
Ace Therapeutics specializes in parasitology and has established a parasite genetic engineering technology platform designed to provide genetic engineering services for a variety of parasitic diseases to clients worldwide. We are able to provide transfection services for Toxoplasma gondii to our global clients, laying the foundation for in-depth elucidation of mechanistic studies.
We have established the Toxoplasma gene transfection system, mainly by electrotransformation method. If you want to know more, you are welcome to consult us.
Electrically stimulated transformation methods
Application of transgenic Toxoplasma gondii
Delivery content: experiment report and products of Toxoplasma gondii gene transfection
Test fee: please get it through online inquiry.